NeuroVentures Capital
NeuroVentures Capital is a Series A, early-growth venture capital firm based in Boston, MA investing in Other, Healthcare, AI / ML. The firm typically writes $2.5M–$10.0M checks and has 2 portfolio companies in our records.
- Check size
- $2.5M–$10.0M
- Portfolio
- 2 companies on record
- Partners
- 1 listed
- Stage
- Series A, early-growth
- Sectors
- Other, Healthcare, AI / ML
- HQ
- Boston, MA
- AUM
- Not in our records
Last verified: 2026-07-12
Series A, early-growth
$2.5M – $10.0M
2+ companies
1 partner
Investment Thesis
Focused exclusively on investing in innovations that advance neuroscience and brain health, leveraging AI and digital tools.
How NeuroVentures Capital invests
NeuroVentures Capital is a vc firm based in Boston, MA. The firm invests at the Series A, early-growth stages, with a focus on Other, Healthcare, AI / ML. It does not invest in Media, Consumer, Hardware.
NeuroVentures Capital typically writes checks of $2.5M–$10.0M per investment.
NeuroVentures Capital has backed 2 companies in our records, including CereScan, BrainCheck.
Partners & Team
Dr. Emily Carter
General Partner
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (2)
Other
CereScan
BrainCheck
- •Raising at Series A, early-growth? You're squarely in their sweet spot.
- •Lead with your fit in Other, Healthcare, AI / ML — the sectors they actively back.
- •Size your ask to their typical $2.5M – $10.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Dr. Emily Carter, General Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if NeuroVentures Capital is a match for your startup
Upload your pitch deck to see how well you match with NeuroVentures Capital and 10,000+ other investors.
Is this your profile? Request a correction or removal